Quarterly report pursuant to Section 13 or 15(d)

Investment in Joint Venture (Details)

v3.22.1
Investment in Joint Venture (Details)
3 Months Ended
Mar. 31, 2022
USD ($)
director
Mar. 31, 2021
USD ($)
Dec. 31, 2021
USD ($)
Feb. 25, 2020
USD ($)
Mar. 24, 2019
USD ($)
Schedule of Equity Method Investments [Line Items]          
IP support agreement, number directors, actual | director 0        
FlyBlade India          
Schedule of Equity Method Investments [Line Items]          
Investment in joint venture, amount         $ 200,000
Investment in joint venture, percent 10.00%       10.00%
IP support agreement, gross revenue, percent 4.00%        
IP support agreement, contingent profit percentage payment percent 3.00%        
IP support agreement, profit threshold amount $ 3,500,000        
Royalty income 12,000 $ 19,000      
FlyBlade India | Corporate Joint Venture          
Schedule of Equity Method Investments [Line Items]          
Non-current assets due from joint venture 132,000   $ 120,000    
FlyBlade India | Maximum          
Schedule of Equity Method Investments [Line Items]          
IP support agreement, gross revenue, gross revenue, amount 10,000,000        
IP support agreement, gross revenue, threshold for quarterly royalties $ 40,000,000        
FlyBlade India | Minimum          
Schedule of Equity Method Investments [Line Items]          
IP support agreement, gross revenue, quarterly royalties, percent 3.00%        
IP support agreement, gross revenue, threshold for quarterly royalties $ 10,000,000        
IP support agreement, gross revenue, quarterly royalties on gross revenues, second threshold percent 1.50%        
IP support agreement, number of directors authorized by percent of ownership | director 5        
FlyBlade India | Hunch          
Schedule of Equity Method Investments [Line Items]          
Investment in joint venture, amount       $ 1,800,000  
Investment in joint venture, percent       90.00%  
IP support agreement, number of directors authorized by percent of ownership | director 3